Version Française
NEWS RSS
22/07/2017
"Risk minimization in data anonymization process"

Come and join us in Barcelona for the 2016 PhUse annual conference. ...

22/07/2017
“The new biosimilar market” / « Le nouveau marché des biosimilaires » - The 7th annual conference of DII.

“The new biosimilar market” / « Le nouveau marché des biosimilaires » - The 7th annual confer...

22/07/2017
Afcros - “Clinical Research Day”.

Afcros - “Clinical Research Day” - January 26,2017...

22/07/2017
[Conference] Meet Keyrus Biopharma at the "IFB eHealth Day 2017: patient health data in policy and research"

[Conference] Meet Keyrus Biopharma at the "IFB eHealth Day 2017: patient health data in pol...

All news
Our activity areas

Biodrugs

Today, the innovative biotechnology companies are the source of a significant proportion of drugs under development.

The biotech companies and the biodrugs can fulfil the requirement for a medication which is tailored to individual need and more efficient.

For the efficient development of these biodrugs, these companies often wish to be guided and advised by project management professionals (especially in clinical trials).

Based on its business expertise, Keyrus Biopharma has developed a special “Expert to Expert” relationship with biotech companies.